Clinical Trials
3 trialsNCT06475755 2024-06-26
Neoadjuvant/Adjuvant Tislelizumab Combined With Anlotinib and Platinum Doublet Chemotherapy With Resectable NSCLC
Tang-Du Hospital
Phase 2 Not yet recruiting
NCT05507606 2022-08-19
Study of Osimertinib+Bevacizumab+Chemotherapy for EGFR+ Advanced Non-Small Cell Lung Cancer With Concurrent Mutations
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Unknown
NCT03461185 2018-03-09
Anti-angiogenesis Combine With EGFR-TKI in Advanced Non-squamous Non Small Cell Lung Cancer
Xinqiao Hospital of Chongqing
Phase 2 Unknown